A comprehensive Nature Reviews analysis identifies three critical clinical advances reshaping osteomyelitis management. Advanced imaging, particularly MRI combined with clinical assessment, achieves diagnostic sensitivity exceeding 90%, enabling earlier and more accurate detection of bone infections. Standard treatment protocols require 4-6 weeks of antimicrobial therapy; however, methicillin-resistant Staphylococcus aureus (MRSA) complicates approximately 30 percent of hospital-acquired cases, necessitating careful antimicrobial stewardship. Importantly, oral antibiotic regimens now offer clinicians effective alternatives to intravenous therapy for carefully selected patients, potentially improving quality of life and reducing healthcare costs. These evidence-based approaches enable physicians to personalize osteomyelitis treatment based on individual patient characteristics, infection severity, and pathogen susceptibility profiles. Read the full article on GMJ Newsroom.
Was this article helpful?
